Abstract
Chronic anterior uveitis is the most common extraarticular manifestation of juvenile idiopathic arthritis (JIA). It is a serious eye disease, potentially threatening the patient with irreversible visual damage to vision loss.
Exact pathogenetic mechanism leading to the intraocular inflammation development is not known, but it is likely to be an interaction of the individual's genetic disposition and external environmental factors. The most common manifestation is chronic anterior uveitis, usually asymptomatic, therefore systematic screening and long-term follow-up of patients at risk is absolutely fundamental.
Recently, the spectrum of therapeutic possibilities for JIA associated uveitis is expanding. In addition to topical treatment, systemic corticosteroids and conventional synthetic disease modifying antirheumatic drugs (csDMARDs), also biological drugs (bDMARDs) are increasingly used.
The objective of this article is to provide an up-to-date overview of this area and recent information on the recommendations for diagnosis and treatment of JIA-associated chronic uveitis.